Margarita A. Timofeeva
Kirov, KIR, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
COVID-19 in Dental Settings: Novel Risk Assessment Approach.
Journal: International journal of environmental research and public health
Published: April 29, 2021
Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: August 21, 2020
Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran-Results of the phase 1 inhibitor cohort.
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 24, 2020
SHP656, a polysialylated recombinant factor VIII (PSA-rFVIII): First-in-human study evaluating safety, tolerability and pharmacokinetics in patients with severe haemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 05, 2019
Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 24, 2018
Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy.
Journal: The New England journal of medicine
Published: July 11, 2017
Association of SLC6A4 gene 5-HTTLPR polymorphism with parameters of simple and complex reaction times and critical flicker frequency threshold in athletes during exhaustive exercise.
Journal: Bulletin of experimental biology and medicine
Published: January 24, 2012
Changes in parameters of laser-induced potentials after transcutaneous electroneurostimulation.
Journal: Bulletin of experimental biology and medicine
Published: January 24, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026